Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TDAY
3301
USA Today Co
TDAY
$1.01B
| $976K | ﹤0.01% |
272,727
+102,409
| +60% | +$343K |
|
3302
CALL
Mattel
MAT
$4.19B
| $972K | ﹤0.01% |
49,300
+4,600
| +10% | +$81.9K |
|
3303
Climb Global Solutions
CLMB
$527M
| $971K | ﹤0.01% |
36,328
+9,124
| +34% | +$241K |
|
3304
Mativ Holdings
MATV
$690M
| $969K | ﹤0.01% |
142,101
-4,332
| -3% | -$25K |
|
3305
RxSight
RXST
$294M
| $969K | ﹤0.01% |
74,510
+19,444
| +35% | +$292K |
|
3306
MarineMax
HZO
$1.15B
| $968K | ﹤0.01% |
38,519
-39,602
| -51% | -$877K |
|
3307
Hingham Institution for Saving
HIFS
$689M
| $967K | ﹤0.01% |
3,894
+1,621
| +71% | +$392K |
|
3308
Chemung Financial Corp
CHMG
$403M
| $967K | ﹤0.01% |
19,942
+5,598
| +39% | +$257K |
|
3309
Grupo Aeroportuario del Sureste
ASR
$8.24B
| $966K | ﹤0.01% |
3,029
+2,739
| +944% | +$854K |
|
3310
UroGen Pharma
URGN
$2.34B
| $961K | ﹤0.01% |
70,154
+25,614
| +58% | +$246K |
|
3311
Mesa Laboratories
MLAB
$631M
| $958K | ﹤0.01% |
10,170
+3,472
| +52% | +$381K |
|
3312
Willis Lease Finance
WLFC
$1.21B
| $956K | ﹤0.01% |
20,088
+9,831
| +96% | +$464K |
|
3313
Scholastic
SCHL
$784M
| $952K | ﹤0.01% |
45,375
+13,449
| +42% | +$245K |
|
|
BULL
3314
Webull Corp
BULL
$4.23B
| $952K | ﹤0.01% |
+79,565
| New | +$1.23M |
|
|
ALX
3315
Alexander's
ALX
$1.39B
| $951K | ﹤0.01% |
4,221
+1,412
| +50% | +$304K |
|
|
DQ
3316
Daqo New Energy
DQ
$988M
| $950K | ﹤0.01% |
62,647
+2,375
| +4% | +$33.7K |
|
3317
BlackBerry
BB
$5.27B
| $949K | ﹤0.01% |
207,278
+90,067
| +77% | +$340K |
|
3318
Vitamin Cottage Natural Grocers
NGVC
$632M
| $948K | ﹤0.01% |
24,151
+12,700
| +111% | +$588K |
|
3319
PUT
iShares US Real Estate ETF
IYR
$4.58B
| $948K | ﹤0.01% |
+10,000
| New | +$933K |
|
|
XRN
3320
Chiron Real Estate Inc
XRN
$480M
| $947K | ﹤0.01% |
27,325
+12,083
| +79% | +$421K |
|
|
KREF
3321
KKR Real Estate Finance Trust
KREF
$493M
| $946K | ﹤0.01% |
107,912
+30,726
| +40% | +$283K |
|
|
LAND
3322
Gladstone Land Corp
LAND
$353M
| $946K | ﹤0.01% |
93,049
+23,419
| +34% | +$230K |
|
3323
Lennar Class B
LEN.B
$20.1B
| $945K | ﹤0.01% |
8,981
+1,727
| +24% | +$179K |
|
3324
Golub Capital BDC
GBDC
$3.48B
| $944K | ﹤0.01% |
64,432
| – | – |
|
3325
Atea Pharmaceuticals
AVIR
$405M
| $942K | ﹤0.01% |
261,774
+90,462
| +53% | +$270K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.